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PATHOMORPOLOGICAL RESEARCH OF VAGINAL 
SUPPOSITORIES “KLIMEDEKS” IN RATS WITH THE 
IRRYTATIVE VAGINITIS
Vaginitis is one of the most common reasons of women during calls to the gynecologist. The best method of their 
treatment is vaginal suppositories that contain antibacterial and anti-inflammatory components. We have studied 
vaginal suppositories “Klimedeks” in female-rats with experimental vaginitis caused by irritants mixture of a gum 
turpentine and dimethylsulfoxide. Treatment of vaginitis was 8 days. At 5th and 8th days animals were taken out 
of the experiment by method of euthanasia and researched vaginal mucosa by histologically. Vaginal suppositories 
“Klimedeks” at the fifth day of the experiment positively impact on the mucosa of the vagina in 87.5 % female rats of 
the animals had no signs of damage and inflammation of the lining of the vagina and superior comparator vaginal 
tablets “Mikozhynaks” for therapeutic effect. On the eighth day of the experiment, 100 % structural and functional 
state of animals mucous membrane of the vagina fully recovered. Placebo did no positive impact on the vagina of rats.
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INTRODUCTIONVaginitis is one of the most common reasons wom-en during calls to the gynecologist. The literature sug-
gest a wide range of prevalence of the disease [4, 14], is due to the fact that a lot of patients don’t consult their 
doctor, are treated yourself, cases of asymptomatic dise- 
ase happen. Infection, inflammation or change the normal 
vaginal microflora can be the causes of vaginitis. Symp-toms that accompany vaginitis are common and often lead 
to self-diagnosis and self-treatment [9, 11].The conditions lead to vaginitis often include: contra-
ception, pregnancy, level of estrogen, intake antibiotics, 
sexually transmitted infection, and so on [12]. More than 
90% of vaginitis are diagnosed during bacterial vagino-
sis, vulvovaginal candidiasis, trichomoniasis [2, 11].
But there vaginitis without infectious origin [7]. There 
are atrophic vaginitis, allergic vaginitis, traumatic vagini-
tis, desquamative inflammatory vaginitis, and so on. Pro- 
longed uncontrolled treatment by antiseptics or antibi-
otics, a menopause, neuroendocrine disorders, using of 
oral contraceptives can be the causes of these types of 
vaginitis, which leads to chronic process [8].
Thinning of the vaginal epithelium makes it more sus-
ceptible to injury and leads to exposure of connective tis-
sue, which makes it vulnerable to inflammation and in-
fection. Low glycogen content in the vaginal epithelium 
leads to reduces the synthesis of lactic acid by lactoba-cilli and to increase the vaginal pH. This promotes the 
growth of excessive intestinal flora, disappearance of lacto-
bacilli and increases inflammation of the vagina and sur- 
rounding skin.
Vaginal suppositories that contain antibacterial and 
anti-inflammatory components are one of the best treat-
ments for vaginal atrophy [13].
Thus, interest presented study the impact of new va- 
ginal suppositories “Klimedeks” [5] include clindamycin, 
metronidazole, dexamethasone, hippophaes oleum, fluco- 
nazole, developed led by prof. Yarnih T. G. (the depart-
ment TL NUPh), on morphological status vaginal muco-
sa against the background of the pilot irritative vaginitis.
MATERIALS AND METHODS
In the research female rats nonlinear were used. Pet 
care (including euthanasia) in the experiment was car-ried out according to the principles of “European Con-
vention for the Protection of vertebrate animals used for 
experimental and other scientific purposes” (Strasbourg, 
1985) [3], approved by the I National Congress on Bio-
ethics (Kyiv, 2000) consistent with the provisions of the 
European Convention for the protection of vertebrate ani-
mals used for experimental and other scientific purposes.
Before the experiment, the females estrous cycle was investigated and selected animals in oestrus-prooestrus phases to minimize differences in the assessment of the 
functional state of the mucous membrane of the vagina when comparing the results. Irytatyvnyy vaginitis mode- led introduction gum turpentine mixture of dimethylsulf- 
oxide in a ratio of 1: 1 vaginally [1]. Animals were divi- ©Dolzhykova O. V., Maloshtan L. M., 2016
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ded into groups as follows: Group 1 – intact animals, 
Group 2 – pathological control (positive control), Group 3 – animals were treated with vaginal suppositories “Klime-
deks”, Group 4 – animals treated with the drug compa- 
red vaginal tablets “Mikozhynaks” (Mekofar, Vietnam), 
Group 5 – animals which used suppository base (placebo) 
in the equivalent amount (negative control). Suppository doses of study drugs and administered in terms of com-
parison by commonly used in experimental pharmacology 
rate of species stability of Rybolovlev Yu. R. [10].
Vaginitis treatment began on the first day of disease and continued for 8 days. Investigated suppositories and preparations comparison was administered 1 time per 
day. At 5 and 8 day experiment on animals were taken out 
by euthanasia. After opening the macroscopic study of vaginal mucosa of all groups animals was investigated and 
vaginal samples were taken for histological investigation.
All samples were fixed in 10 % formalin solution, de- 
hydrated in alcohols of increasing strength and embed-
ded in paraffin [6]. The evaluation of the microprepara-
tions was performed by microscope Granum, micropho-
tography carried digital video camera Granum DSM 310. 
Photos processed on a computer Pentium 2,4 GHz with using Toup View.
Morphological study did with the consulting of Senior 
Researcher Yu. B. Lar’yanovskaya.
RESULTS AND DISCUSSIONThe wall of the vagina of intact control animal con-
sists of mucous, muscular and adventive layers in the micro-
photographs. Structural organization of epithelial mucosa in different parts of the vaginal wall is somewhat varied. 
In the vestibule of vagina is a typical skin type. At the 
distal (tail vagina) is multilayer flat epithelium with kera- 
tinized symptoms (called transitional type). Basal and in-termediate layers were well differentiated and traced mo- derate dipping of epithelial tongues deep into mucosa. 
In the proximal part (close to the odd part of the uterus) epithelial structure depended on the phase of the estrous 
cycle. In the microphotographs in phase prooestrus epi-thelium was a multilayered-prismatic with mucinous cells 
on the surface, in the oestrus phase it was multilayered flat 
keratinized epithelium. The stratum corneum is expres- 
sed very moderate (less expressive than in the distal). 
It should be noted that often in different microphotographs 
observed different stages of development phases prooest- 
rus-oestrus, which differ among themselves by severity 
of features. Vaginal mucosa lamina propria (stroma) had features of dense connective tissue. Closer to the muscle 
layer is changed in the submucosal layer, which looked 
like loose connective tissue. Vascularization was normal, 
the lumen of blood vessels was free and moderately wide. 
Submucosal layer directly changed in the muscle layer. 
Adventive layer is located outside of the muscle layer, con-
sisted of loose connective tissue containing blood vessels 
(Fig. 1).
On the fifth day after administration of a mixture ir-
ritants in 87.5 % of females observed widespread destruc-
tive inflammatory changes all layers of the vaginal wall. 
The mucous layer is in a state of complete destruction, 
heavily infiltrated by mononuclear cells. Submucosal layer 
is very edematic, enlarged, collagen fibers altered dege- 
nerative, inflammatory cell response is located closer to 
the muscular layer. The blood vessels of the stroma mu-
cous layer and submucosal layer paralytic expanded, in 
some of their observed blood cells located on the edge 
(Fig. 2а).
The vagina epithelial layer of other animals was saved, 
but without differentiation layers, superficial epithelium 
layer was in the state of the morphologic alterations, so- metimes whole layer started to exfoliate off completely and stroma at this place was without outer layer. Colla-gen component of the lamina propria of mucous layer 
was very edematic. The stroma was penetrated by red 
blood cells, expressive inflammatory reaction was in the 
submucosal layer (Fig. 2b).In the intact parts of the vaginal wall epithelium re-
tains the ability to functional physiological changes in-
Fig. 1. The epithelium of various parts of mucous membrane of wall of the vagina intact female rats: а – vestibule 
of vagina (typical skin); b – distal part (multilayered keratinized); c-d – proximal part (phase oestrus, prooestrus). 
Hematoxylin-eosin. а-c – х100, d – х200
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Fig. 2. The wall of the vagina of female rats on the 5th day after administration of a mixture irritants: a – necrosis 
with mononuclear infiltration of mucous layer (СО), edema, degeneration of collagen fibers of submucosal layer 
(PP), paralysis of the vascular wall, inflammatory reaction; b – necrobiosis of the surface layers of the epithelium, 
absence of layers differentiation, exfoliation of layer, stroma of mucous is without outer layer and with edema (СО), 
erythrocyte penetration. Inflammation of submucosal layer (PP). Hematoxylin-eosin. х100
Fig. 3. The wall of the vagina of female rats on the 5th day after administration of a mixture irritants. The area 
beyond the zone of destruction: а – proliferation of basal cells (arrows), degeneration of cells intermediate layer of 
the epithelium, edema of stroma mucous membrane (СО), inflammatiory cell reaction in the submucosal layer (PP); 
b – expressive proliferation of epithelial layer. Hematoxylin-eosin. х200; c – distal part (thickened epithelial layer, 
hyperkeratosis, inflammation in the stroma. Hematoxylin-eosin. х100
Fig. 4. The wall of the vagina of female rats on the 8th day after administration of a mixture irritants. Proximal 
part: a – normal state epithelium, remains of inflammation in the stroma, small subepithelial hemorrhage (arrow), 
expansion and plethoric of capillary network (х250). Phase prooestrus. Distal part: b – thickened epithelial layer, 
hyperkeratosis (х200). Phase oestrus. Hematoxylin-eosin
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herent phases of the estrous cycle, although sometimes 
thickening of the epithelial layer traced.
In areas beyond the destructive changes observed 
stromal mucosal edema, inflammation in the submuco- 
sal layer. The epithelium, on the whole, kept the ability 
to physiological changes (phase rrooestrus-oestrus). At 
the same time, in the epithelial layer you can see the pro-
liferation of basal cells, degeneration cell of the interme-
diate layer, sometimes layer lost the typical cells location 
(Fig. 3а). In some places you can see proliferation of epi-
thelial (Fig. 3b).On the 8-th day of the experiment pathologycal chan- 
ges in mucous membrane of the vagina in control group 
were insignificant. Epithelial structure and physiological 
cycle were without changes. Plethoric capillary network 
noted in proximal subepithelial mucous layer some fe-
males, small focal hemorrhages, inflammation remains. 
In places of the distal part epithelial layer thickening, hy-
perkeratosis were saved (Fig. 4а, b, c). In the vaginal mu-
cosa only remains vascular and inflammatory reactions and focal hypertrophic proliferation of epithelial layer in the distal area of the vaginal wall traced.
Administration of vaginal suppositories “Klimedeks” causes positive impact on the state of the mucous mem-
brane of the rats’ vagina, injured by mixture of irritants. 
On the fifth day of the experiment only 12.5 % female 
rats (1 of 8) in the distal mucosa small zone of destruc-tion and  separation from lamina propria mucosa of the 
epithelial layer revealed. Unlike reference pathology were 
less expressive edema, inflammatory cell and vascular 
stroma reaction as in mucosal and submucosal layer in 
it (Fig. 5a). 87.5 % of the animals this group structure 
epithelial layer is preserved, was typical for a particular 
phase of the estrous cycle, stroma mucosa and submu-
cosal layer were not changed (Fig. 5b-c) already on the 
fifth day of the experiment.On the 8-th day after administration of irritants struc-tural organization of epithelial cells vaginal mucosa of 
rats treated with vaginal suppositories “Klimedeks” was 
physiological normal (Fig. 6).
Vaginal tablets do “Mikozhynaks” cause a similar im-
pact on the vaginal wall. On the fifth day after administra-
tion irritants mixture in 2 of 8 females have been very extensive damaged areas of vaginal wall that microsco- 
Fig. 6. The wall of the vagina of female rats treated with vaginal suppositories “Klimedeks” on the 8-th day after 
administration of a mixture irritants. Structural organization of the mucous membrane was normal  
(a – distal, b – proximal). Phase oestrus. Hematoxylin-eosin. x200
Fig. 5. The wall of the vagina of female rats after vaginal suppositories “Klimedeks” treatment during the 5th day 
after administration of a irritants mixture: a – micro-defects of epithelial layer, its separation from lamina propria 
mucosa, moderate edema of the stroma (CO) of the submucosal layer (PP) inflammatory response; b – the normal 
state of the epithelial layer of the proximal and c – distal vaginal wall (phase oestrus). Hematoxylin-eosin. x200
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pically was not different from control disease (Fig. 7a). Even 2 rats had smaller destructive changes of mucosa 
(Fig. 7b). In the intact parts of the epithelial layer was 
thickened slightly, but structurally and functionally mu-
cosa and submucosal stroma layer were normal (Fig. 7c). The vaginal wall of remaining animals was without de-struction. Epithelial layer of the distal vaginal wall was 
often thickened, epithelial layer of the proximal vaginal 
wall ranged in thickness from normal to thin. In one case traced focal proliferation in violation of structural charac-
teristics of epithelial layer and significant penetration into 
subordinate stroma were registered (Fig. 8).
The reference-drug of vaginal tablets “Mikozhynaks” during 5 days of the experiment were worse than vagi-
nal suppositories “Klimedeks” in expressive positive im-pact on the vaginal wall of female rats.
On the background of placebo administration du- ring 5 days of the experiment vaginal wall of rats prac- tically do not have positive changes compared to the 
control pathology. On the 8th day, as in the control pa-thology group was a natural regression of pathological process.
CONCLUSIONS1. Vaginal suppositories “Klimedeks” reduced edema, 
inflammatory cellular and vascular reactions in the 
stroma of the mucous membrane, and in the sub-mucosal layer and helped restore the vaginal muco-
sa, which indicates apparent anti-inflammatory ef- fect on the experimental models of irritative vagi-
nitis caused by a mixture of turpentine oil and di-methylsulfoxide.2. Vaginal suppositories “Klimedeks” during the expe- rimental study exceeded reference-drug of vaginal 
tablets “Mikozhynaks” with the ability to restore the 
mucous membrane in the background irritative vaginitis.3. Vaginal suppositories “Klimedeks” are perspective for using as a drug for the treatment of vaginitis.
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ПАТОМОРФОЛОГИЧЕСКОЕ ИССЛЕДОВАНИЕ ВАГИНАЛЬНЫХ СУППОЗИТОРИЕВ «МЕЛАНИЗОЛ» 
НА ФОНЕ ИРРИТАТИВНОГО ВАГИНИТА
Представлены патоморфологические исследования влияния вагинальных суппозиториев 
«Меланизол» на ход ирритативного вагинита, вызванного смесью живичного скипидара и диме-
тилсульфоксида у крыс. Вагинальные суппозитории «Меланизол» на фоне вагинита проявили 
лечебный эффект, который проявился в предотвращении возникновения некротически-вос-
палительного повреждения и способствовании заживлению дефектов слизистой оболочки 
и подслизистого слоя стенки влагалища. На модели экспериментального вагинита было до-
казано, что суппозитории «Гравагин» уступали по выразительности положительного вли-
яния на состояние влагалищной стенки крыс-самок, что проявлялось в наличии достаточно 
крупных очагов деструкции влагалищной стенки, очагов воспаления, отека коллагеновых во-
локон. Вагинальные суппозитории «Меланизол» являются перспективными для применения 
в качестве препарата для лечения неспецифических вагинитов, сопровождающихся деструк-
тивно-воспалительными реакциями.
Ключевые слова: патоморфологические исследования; суппозитории вагинальные; масло 
чайного дерева; метронидазол
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ПАТОМОРФОЛОГІЧНЕ ДОСЛІДЖЕННЯ ВАГІНАЛЬНИХ СУПОЗИТОРІЇВ «МЕЛАНІЗОЛ» НА ТЛІ 
ІРИТАТИВНОГО ВАГІНІТУ
Представлені патоморфологічні дослідження впливу вагінальних супозиторіїв «Меланізол» 
на перебіг іритативного вагініту, викликаного сумішшю живичного скипидару і диметил-
сульфоксиду у щурів. Вагінальні супозиторії «Меланізол» на тлі вагініту виявили лікувальний 
ефект, який проявився у запобіганні виникненню некротично-запального пошкодження та 
сприянні загоєнню дефектів слизової оболонки та підслизового прошарку стінки піхви. На мо-
делі експериментального вагініту було доведено, що супозиторії «Гравагін» поступалися за 
виразністю позитивного впливу на стан піхвової стінки щурів-самиць, що проявлялося у на-
явності достатньо великих осередків деструкцій піхвової стінки, вогнищ запалення, набряку 
колагенових волокон. Вагінальні супозиторії «Меланізол» є перспективними для застосуван-
ня в якості препарату для лікування неспецифічних вагінітів, що супроводжуються деструк-
тивно-запальними реакціями.
Ключові слова: патоморфологічні дослідження; супозиторії вагінальні; олія чайного дерева; 
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